Industry n/a · SIC —
DR REDDYS LABORATORIES LTD
RDY
Latest revenue
—
as of —
Latest net income
—
as of —
Net margin
—
as of —
Price · 5Y
▲ +0.1% / yr▼ 13.7 pts / yr vs S&P 500▲ 0.3% total
Compare:
Live market
delayed ≤15 min$13.60
▲ 0.37%
- Market cap
- $11.35B
- Enterprise value
- $11.35B
- P/E (trailing)
- —
- Forward P/E
- —
- P/B
- —
- Dividend yield
- 0.7%
- 52-wk high
- $16.17
- 52-wk low
- $12.19
- Beta
- —
- Shares out
- 834.5M
5-year trend
No quarterly data ingested yet for this company.
About RDY
Business description and risk factors will appear here once RDY's latest filing is fully ingested.
Earnings tracker
Not enough quarterly history for RDY yet to draw an earnings tracker.
Industry trend
Industry · SIC —
No data yet for industry average
Your notes
Keep private notes on RDY — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
No insider transactions on file for RDY in the last 12 months.
Source: SEC Form 4 filings. Backfill runs nightly.
Who owns RDY
No institutional holdings on file for RDY yet.
Source: SEC Form 13F-HR. Updated quarterly (45-day filing lag).
Top questions investors are asking
Coming once RDY's latest filing finishes processing.